NCT02540148View on ClinicalTrials.gov

Transpalpebral Micro-Current Electrical Stimulation for the Treatment of Dry Age-Related Macular Degeneration

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Age-Related (Dry) Macular Degeneration
Interventions
DEVICE

Nova Oculus™ Micro-current electrical stimulation

Active treatment with transpalpebral micro-current electrical stimulation device, 3 sessions within 5 days of the 1st treatment. 1 session during weeks 2, 14 and 26.

DEVICE

Nova Oculus™ Micro-current electrical stimulation - Sham treatment

Non-active treatment with transpalpebral micro-current electrical stimulation SHAM device, 3 sessions within 5 days of the 1st treatment. 1 session during weeks 2, 14 and 26.

Trial Locations (1)

V3K 3N9

Dr. Kevin Parkinson, Coquitlam

All Listed Sponsors
lead

The Eye Machine Canada Inc.

INDUSTRY

NCT02540148 - Transpalpebral Micro-Current Electrical Stimulation for the Treatment of Dry Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter